ORGANOGENESIS HOLDINGS INC. Earnings Per Share, Basic and Diluted
ORGANOGENESIS HOLDINGS INC. (ORGO) reported Earnings Per Share, Basic and Diluted of -$0.05 per share for the 3-month period ending 2020-06-30, per its 10-Q filed 2020-08-10.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2020-08-10
- ORGANOGENESIS HOLDINGS INC. earnings per share, basic and diluted for the quarter ending 2020-06-30 was -$0.05.
- ORGANOGENESIS HOLDINGS INC. earnings per share, basic and diluted for the quarter ending 2020-03-31 was -$0.16.
- ORGANOGENESIS HOLDINGS INC. earnings per share, basic and diluted for the quarter ending 2019-12-31 was -$0.03.
- ORGANOGENESIS HOLDINGS INC. earnings per share, basic and diluted for the quarter ending 2019-09-30 was -$0.12.
- ORGANOGENESIS HOLDINGS INC. earnings per share, basic and diluted for fiscal 2019 was -$0.44.
- ORGANOGENESIS HOLDINGS INC. earnings per share, basic and diluted for fiscal 2018 was -$0.94.
- ORGANOGENESIS HOLDINGS INC. earnings per share, basic and diluted for fiscal 2017 was -$0.14.
- ORGANOGENESIS HOLDINGS INC. earnings per share, basic and diluted for fiscal 2016 was -$0.27.
| Period end | Earnings Per Share, Basic and Diluted 1 month | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 3 month as first filed | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 6 month as first filed | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 9 month as first filed | Earnings Per Share, Basic and Diluted 12 month | Earnings Per Share, Basic and Diluted 12 month as first filed |
|---|---|---|---|---|---|---|---|---|---|
| 2020-06-30 | -$0.05 10-Q · filed 2020-08-10 | -$0.21 10-Q · filed 2020-08-10 | |||||||
| 2020-03-31 | -$0.16 10-Q · filed 2020-05-11 | ||||||||
| 2019-12-31 | -$0.03 derived: net income ÷ weighted average shares · filed 2022-03-01 | -$0.15 derived: net income ÷ weighted average shares · filed 2022-03-01 | -$0.44 10-K · filed 2020-03-09 | ||||||
| 2019-09-30 | -$0.12 10-Q · filed 2019-11-12 | -$0.40 10-Q · filed 2019-11-12 | |||||||
| 2019-06-30 | -$0.11 10-Q · filed 2020-08-10 | -$0.28 10-Q · filed 2020-08-10 | |||||||
| 2019-03-31 | -$0.17 10-Q · filed 2020-05-11 | ||||||||
| 2018-12-31 | -$0.12 10-K · filed 2019-03-18 | -$0.86 derived: net income ÷ weighted average shares · filed 2021-03-16 | -$0.90 derived: net income ÷ weighted average shares · filed 2021-03-16 | -$0.94 10-K · filed 2020-03-09 | |||||
| 2018-09-30 | -$0.19 10-Q · filed 2019-11-12 | $0.36 10-Q · filed 2018-11-09 | $0.04 derived: net income ÷ weighted average shares · filed 2019-11-12 | -$0.83 10-Q · filed 2019-11-12 | $0.16 10-Q · filed 2018-11-09 | -$0.08 derived: net income ÷ weighted average shares · filed 2020-03-09 | |||
| 2018-06-30 | -$0.30 10-Q · filed 2019-08-09 | -$0.09 10-Q · filed 2018-08-07 | -$0.65 10-Q · filed 2019-08-09 | -$0.20 10-Q · filed 2018-08-07 | -$0.16 derived: net income ÷ weighted average shares · filed 2020-03-09 | -$0.28 derived: net income ÷ weighted average shares · filed 2020-03-09 | |||
| 2018-03-31 | -$0.35 10-Q · filed 2019-05-10 | -$0.11 10-Q · filed 2018-05-10 | -$0.18 derived: net income ÷ weighted average shares · filed 2020-03-09 | -$0.34 derived: net income ÷ weighted average shares · filed 2020-03-09 | -$0.42 derived: net income ÷ weighted average shares · filed 2020-03-09 | ||||
| 2017-12-31 | -$0.13 10-K · filed 2018-03-14 | -$0.89 derived: net income ÷ weighted average shares · filed 2020-03-09 | -$0.92 derived: net income ÷ weighted average shares · filed 2020-03-09 | -$0.14 10-K · filed 2020-03-09 | -$0.48 10-K · filed 2018-03-14 | ||||
| 2017-09-30 | -$0.30 10-Q · filed 2018-11-09 | -$0.32 derived: net income ÷ weighted average shares · filed 2018-11-09 | -$0.34 10-Q · filed 2018-11-09 | -$0.35 10-Q · filed 2017-11-14 | |||||
| 2017-06-30 | -$0.02 10-Q · filed 2018-08-07 | $0.04 10-Q · filed 2017-08-11 | -$0.04 10-Q · filed 2018-08-07 | $0.06 10-Q · filed 2017-08-11 | |||||
| 2017-03-31 | -$0.02 10-Q · filed 2018-05-10 | $0.02 10-Q · filed 2017-05-12 | |||||||
| 2016-12-31 | -$0.02 10-K · filed 2018-03-14 | -$0.27 10-K · filed 2019-03-18 | -$0.03 10-K · filed 2017-03-28 | ||||||
| 2016-09-30 | $0.00 10-K · filed 2018-03-14 | $0.00 10-Q · filed 2017-11-14 | |||||||
| 2016-06-30 | $0.00 10-K · filed 2018-03-14 | $0.00 10-Q · filed 2017-08-11 | |||||||
| 2016-03-31 | $0.00 10-K · filed 2018-03-14 | ||||||||
| 2015-12-31 | $0.00 10-K · filed 2018-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |